MAPT and Mental deterioration: Moreover, over half of the patients with PD dementia (PDD) also have significant AD-related pathology with abnormally deposited α-synuclein, amyloid-β and tau proteins in the PDD brain, including in the hippocampus which correlates to the severity of cognitive decline in patients with PDD (Kalaitzakis and Pearce, 2009).